Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo. - Wikidata - awgldk - TriplyDB

Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.

Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.

http://www.wikidata.org/entity/Q43461615

about

Tissue distribution of human AKR1C3 and rat homolog in the adult genitourinary system Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators.Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside PPARgamma and MEK Interactions in Cancer Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer.Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes.Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.PPAR alpha and PPAR gamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats.Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.Proliferative and nonproliferative lesions of the rat and mouse urinary system.Trans-species comparison of PPAR and RXR expression by rat and human urothelial tissues.Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.

P2860

Q24328776-F4E85D52-ABAF-43F3-9EDD-A6C7C8C213B8 Q35216684-4E91AFCF-5F51-4306-ADB1-F08672700E09 Q36056207-84404DA1-42B3-4B4D-9511-2675FADC660F Q36737285-1EA4C3D6-8BB4-4A1D-824D-64578C6D3912 Q37077098-7B32864D-BC64-455A-9A20-D20A2EE2A5D6 Q37699907-B5213BE3-FEBB-4636-B9D6-9BE05755EA13 Q38061184-BFA2C6FD-3352-440F-AE15-1750B6A237DB Q38160494-1F070F78-0D2A-4C46-B0D3-4E63820C4CF5 Q38818082-67F10382-7E18-43C1-BAEC-60C59380D8B8 Q43222810-6371B9EA-3BDF-449B-9D3D-C46ADD4BBEF0 Q46599209-8B5A8824-5F7D-40FA-AC9D-A602748BBE6B Q48636042-80F32CDD-6D6B-4DCA-9F2F-34F3A14BAF2A Q53321831-C2ED930D-CA91-4C5F-BA1E-F34679177932 Q53338744-AA2D0FCE-4CD1-4F1A-9B2A-BCA19F59C149 Q55356554-823D82BA-38AE-4005-9FEF-668D4AD9CA2A

P2860

Generalized cellular hypertrophy is induced by a dual-acting PPAR agonist in rat urinary bladder urothelium in vivo.

http://www.wikidata.org/entity/Q43461615

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Generalized cellular hypertrop ...... ry bladder urothelium in vivo.

@en

Generalized cellular hypertrop ...... ry bladder urothelium in vivo.

@nl

type

label

Generalized cellular hypertrop ...... ry bladder urothelium in vivo.

@en

Generalized cellular hypertrop ...... ry bladder urothelium in vivo.

@nl

prefLabel

Generalized cellular hypertrop ...... ry bladder urothelium in vivo.

@en

Generalized cellular hypertrop ...... ry bladder urothelium in vivo.

@nl

P1433

Q43461615-5E616DE3-AFD7-4481-9A19-14612624CD44

P1476

Q43461615-FF77355E-2FC7-4B4F-A2CD-2FD9AC266BF2

P2093

Q43461615-45C8D23B-449E-4E39-8D16-9E579C5D7890

Q43461615-5F32AC21-9D0A-4C7D-B957-6AAB4A4849A0

Q43461615-7D8FA799-8475-421E-932C-9659BEB3A65F

Q43461615-83D69620-80E6-49A8-BA41-378DDE8379E7

Q43461615-8C777AB7-628B-4B84-9546-C3C8D8312915

Q43461615-92A2878D-5C21-4ADA-BA43-919920C00B51

Q43461615-9EC6656A-24AE-4575-82D7-FC723C1A3437

Q43461615-C6B6C099-00B1-48C9-B2A7-2A62797A4E67

Q43461615-C77DA77F-7289-4FE1-A36F-87BA9B4D78A6

Q43461615-E827EC99-ADCA-45F3-B443-1685916635AF

P2860

Q43461615-0015CD93-9A4A-490D-BEDB-46C15DAECA38

Q43461615-032DE563-2AA7-47A9-9D09-0515A37F07AD

Q43461615-133CA6D1-B481-4471-A04C-483C44F7FDA4

Q43461615-139DBBBB-3894-49EB-A422-E9136C30A9A8

Q43461615-2AEC664B-2141-494A-9EF9-E81FF02711EE

Q43461615-2FDE5082-5812-4A82-B724-68F83FB1F6BF

Q43461615-64943923-B61A-4E75-8761-832F7A692742

Q43461615-8D0B2BC0-EDC7-48B4-A053-CE5AB59AE804

Q43461615-8E8CCD0C-D348-4FC5-8E6E-3A1F513BF9A6

Q43461615-97573706-09ED-412C-99F6-154DEAAE6B63

P304

Q43461615-C76C1A20-70BB-4FC4-BE2F-DCED2B98E9E7

P31

Q43461615-F68F371A-7B8E-4899-8DF0-07CBF5B630D4

P356

Q43461615-0CD4EF26-F560-42B7-B335-A9B4B86A2562

P407

Q43461615-F47C292A-AEC9-4F57-ADB1-8B37DE76D152

P433

Q43461615-C435C9FB-3624-479A-AB8C-EC546B6F2E2D

P478

Q43461615-5B7E2B35-6951-4A8E-A864-F0A950573269

P577

Q43461615-3F967DD6-113B-4FDF-9623-D3D66F69293C

P5875

Q43461615-E8629120-2299-44AD-AB46-B34E4BC7A835

P698

Q43461615-57752CB3-CA2A-4C90-BBF2-1A083653D7A9

P356

01926230500214657

P1433

Toxicologic Pathology

P1476

Generalized cellular hypertrop ...... ry bladder urothelium in vivo.

@en

P2093

Anne Charlotte Hegelund

http://www.w3.org/2001/XMLSchema#string

Hanne V Andersen

http://www.w3.org/2001/XMLSchema#string

Henriette S Nielsen

http://www.w3.org/2001/XMLSchema#string

Inger Thorup

http://www.w3.org/2001/XMLSchema#string

Ingrid Sjogren

http://www.w3.org/2001/XMLSchema#string

Lars Iversen

http://www.w3.org/2001/XMLSchema#string

Lis Jørgensen

http://www.w3.org/2001/XMLSchema#string

Marianne B Jensen

http://www.w3.org/2001/XMLSchema#string

Martin B Oleksiewicz

http://www.w3.org/2001/XMLSchema#string

Peter R Brinck

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase.

Everything you wanted to know about the bladder epithelium but were afraid to ask.

Roles of PPARs in health and disease.

Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors.

Peroxisome-proliferator-activated receptors and cancers: complex stories.

Signaling control of mRNA translation in cancer pathogenesis.

PPAR trilogy from metabolism to cancer.

Quantitative cytochemical aspects of a combined feulgen-naphthol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells.

P304

552-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/01926230500214657

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7682449

http://www.w3.org/2001/XMLSchema#string

P698

16076770

http://www.w3.org/2001/XMLSchema#string